Directory Intermedianta Dofaminomimetiki Norprolak
This page is translated automatically with a help of Google Translate

Norprolak

See also Quinagolide

Roman name

Norprolac

Storage conditions

List B. At temperatures below 30 ° C (not freezing)

Shelf life

3 years

The registration

012402/01-2000

Of drugs

Selective agonist, V2-dofaminovykh receptors. Suppress the secretion of prolactin-hormone front of pituitary catalyst molokoobrazovanie without affecting the normal levels gipofizarnah other hormones.

Indications for use

Giperprolaktinemia (elevated in the blood hormone glands of spurring molokoobrazovanie) idiopathic (origin uncertain), or razvivashayasa against micro or pituitary macroadenoma with clinical manifestations, as galactorea (molokoistechenie outside breastfeeding), oligomenorea (menstruation periods from a few hours to two days), amenorea (lack of menstruation), infertility, reduced sexual desire.

Dosing and Administration

Doses set individually. The initial dose was 46 mg once a day over a period of three days. Over the next three days appoint daily in the daily dose of 0.05 mg. Since the 7th day of treatment daily daily intake is 0,075 mg.

Side-Effects

Headache, dizziness, weakness, nausea, vomiting; More rarely fall. In a few cases may develop severe psychosis passing of the product. Anorexia (lack of appetite), pains in the abdomen, constipation, diarrhea. The decline in blood pressure; Zalojennosti nose. On rare occasions there has been ortostaticski collapse (sharp decline in blood pressure in the transition from the horizontal to the vertical position).

Contraindications

Hypersensitivity to the drug. Caution must be exercised in the appointment norprolaka patients with the disorder (history) indicate mental illness or disturbance. Those whose work requires quick mental and motor response (such as drivers of vehicles) should designate norprolak with caution.

Form of

Answers to 0,025; 0.05; 0.075 and 0.15 mg.

All products of this group

0